Teva 'Not Optimistic' About Sealing $23B Opioid Deal Soon
Teva Pharmaceuticals probably won't finalize a major opioid settlement until the coronavirus pandemic abates and allows for the resumption of courtroom trials that tend to bring litigants to the negotiating table,...To view the full article, register now.
Already a subscriber? Click here to view full article